Sarcoidosis vasculitis and diffuse lung diseases

Published: 2013-09-01

Editorial

Section 1: Update on idiopathic pulmonary fibrosis: epidemiology, natural history, disease staging and pathogenesis

Epidemiology of idiopathic pulmonary fibrosis in Europe – an update

I. Annesi-Maesano, H. Nunes, B. Duchemann, et al.
Abstract 320 | PDF Downloads 77

Page 6-12

Classification, natural history and staging of idiopathic pulmonary fibrosis

V. Poletti, J. Egan
Abstract 227 | PDF Downloads 61

Page 13-20

Section 2: Update on idiopathic pulmonary fibrosis: pathophysiology and future perspectives

Molecular biomarkers in idiopathic pulmonary fibrosis and disease severity

B. Crestani
Abstract 112 | PDF Downloads 34

Page 27-32

Section 3: Management of idiopathic pulmonary fibrosis and implications for clinical practice - A case study series

Management of idiopathic pulmonary fibrosis and pulmonary hypertension

K. Schulze
Abstract 83 | PDF Downloads 39

Page 33-36

Gastro-oesophageal reflux and idiopathic pulmonary fibrosis

C. Vancheri
Abstract 85 | PDF Downloads 47

Page 37-39

Pirfenidone treatment in a patient with IPF and possible initial hypersensitivity pulmonitis

F. Cinetto, C. Agostini
Abstract 108 | PDF Downloads 39

Page 40-43

Management of a patient with familial idiopathic pulmonary fibrosis

S. Böing, S. George, L. Hagmeyer
Abstract 80 | PDF Downloads 57

Page 48-51

Long-term management of IPF with pirfenidone – a clinical case study with 5 years follow-up

L. Richeldi, G. Sgalla, S. Cerri
Abstract 174 | PDF Downloads 51

Page 52-62

Conclusions